Provided by Tiger Fintech (Singapore) Pte. Ltd.

MediciNova

1.55
+0.08005.44%
Post-market: 1.550.00000.00%16:05 EDT
Volume:13.85K
Turnover:21.05K
Market Cap:76.02M
PE:-6.88
High:1.58
Open:1.51
Low:1.46
Close:1.47
Loading ...

Company Profile

Company Name:
MediciNova
Exchange:
NASDAQ
Establishment Date:
2000
Employees:
13
Office Location:
4275 Executive Square,Suite 300,La Jolla,California,United States
Zip Code:
92037
Fax:
858 404 0048
Introduction:
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. The company's product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic and other diseases, including nonalcoholic fatty liver disease and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. It has license agreements with Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals, Ltd.; and Meiji Seika Kaisha, Ltd. The company was incorporated in 2000 and is headquartered in La Jolla, California.

Directors

Name
Position
Jeff Himawan
Chairman
Yuichi Iwaki
Director,President and Chief Executive Officer
Yoshio Ishizaka
Director
Yutaka Kobayashi
Director

Shareholders

Name
Position
Yuichi Iwaki
Director,President and Chief Executive Officer
Ryan Selhorn
Chief Financial Officer
Geoffrey O'Brien
Vice President
Kazuko Matsuda
Chief Medical Officer
Masatsune Okajima
Vice President and Head of Japanese Office